Sanitation Lead
MycoWorksSalary not specified
- Full Time
- Mid-level (3 to 4 years), Senior (5 to 8 years)
About MycoWorks
MycoWorks produces a leather alternative called Reishi™, made from mycelium, which is a part of fungus. This material is designed to be sustainable and is appealing to fashion brands and designers seeking eco-friendly options. Reishi™ has already been used in luxury products, such as handbags and hats. The company has recently expanded its operations by opening a large facility in South Carolina, which is the first commercial-scale plant dedicated to producing Fine Mycelium™. This expansion reflects MycoWorks' commitment to meeting the increasing demand for sustainable materials in the fashion industry. Unlike traditional leather, Reishi™ offers a more environmentally friendly choice without compromising on quality. MycoWorks aims to capture a significant share of the growing leather goods market, which is projected to reach over $720 billion by 2030.
Emeryville, CaliforniaHeadquarters
2013Year Founded
$181.9MTotal Funding
SERIES_CCompany Stage
Industrial & Manufacturing, Consumer GoodsIndustries
201-500Employees
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Equity
401(k) Retirement Plan
FSA Accounts
Paid Parental Leave
Paid Holidays
Unlimited Paid Time Off
Risks
Competition from companies like Bolt Threads and Ecovative may impact market share.
Reliance on luxury markets could limit growth during economic downturns.
Operational challenges in large-scale production may affect profitability if not managed well.
Differentiation
MycoWorks offers Reishi™, a unique mycelium-based leather alternative, unlike traditional materials.
The company operates the world's first commercial-scale Fine Mycelium™ plant in South Carolina.
Reishi™ is integrated into luxury items, showcasing its premium market positioning.
Upsides
Growing demand for sustainable fashion boosts Reishi™'s market potential and adoption.
Partnerships with luxury brands like Hermès and Ligne Roset enhance brand visibility and credibility.
The new South Carolina facility enables efficient scaling to meet increasing demand.
Funding
Total raised$181.90 M
Latest valuation$625.00 M
StageSERIES_C
SERIES C
12/31/2021$125
$625.00 MSERIES B
10/31/2020$45
$225.00 MSERIES A
1/31/2020$17
$85.00 M